Continue to site >
Trending ETFs

Name

Price

Aum/Mkt Cap

YIELD & DIV

Exp Ratio

Watchlist

$231.68

$50.5 B

0.16%

$0.37

0.32%

Vitals

YTD Return

7.4%

1 yr return

14.0%

3 Yr Avg Return

10.3%

5 Yr Avg Return

11.4%

Net Assets

$50.5 B

Holdings in Top 10

40.8%

52 WEEK LOW AND HIGH

$228.8
$207.38
$246.56

Expenses

OPERATING FEES

Expense Ratio 0.32%

SALES FEES

Front Load N/A

Deferred Load N/A

TRADING FEES

Turnover 18.00%

Redemption Fee N/A


Min Investment

Standard (Taxable)

$3,000

IRA

N/A


Fund Classification

Fund Type

Open End Mutual Fund

Investment Style

Health


Name

Price

Aum/Mkt Cap

YIELD & DIV

Exp Ratio

Watchlist

$231.68

$50.5 B

0.16%

$0.37

0.32%

VGHCX - Profile

Distributions

  • YTD Total Return 7.4%
  • 3 Yr Annualized Total Return 10.3%
  • 5 Yr Annualized Total Return 11.4%
  • Capital Gain Distribution Frequency None
  • Net Income Ratio 0.95%
DIVIDENDS
  • Dividend Yield 0.2%
  • Dividend Distribution Frequency None

Fund Details

  • Legal Name
    Vanguard Health Care Fund
  • Fund Family Name
    Vanguard
  • Inception Date
    May 23, 1984
  • Shares Outstanding
    N/A
  • Share Class
    Inv
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    Jean Hynes

Fund Description

The fund invests at least 80% of its assets in the stocks of companies principally engaged in the development, production, or distribution of products and services related to the health care industry. These companies include, among others, pharmaceutical firms, medical supply companies, and businesses that operate hospitals and other health care facilities. The adviser may also consider companies engaged in medical, diagnostic, biochemical, and other research and development activities. The fund may invest up to 50% of its assets in foreign stocks. It is non-diversified.


VGHCX - Performance

Return Ranking - Trailing

Period VGHCX Return Category Return Low Category Return High Rank in Category (%)
YTD 7.4% -80.8% 25.3% 44.39%
1 Yr 14.0% -28.4% 77.3% 78.39%
3 Yr 10.3%* -0.1% 33.4% 71.62%
5 Yr 11.4%* 2.1% 32.2% 79.02%
10 Yr 15.5%* 9.8% 21.9% 74.19%

* Annualized

Return Ranking - Calendar

Period VGHCX Return Category Return Low Category Return High Rank in Category (%)
2020 3.6% -13.6% 178.2% 88.44%
2019 9.3% 3.8% 63.8% 97.24%
2018 -7.3% -49.7% 21.5% 51.09%
2017 11.2% -59.8% 54.4% 78.52%
2016 -16.2% -36.6% 11.6% 57.03%

Total Return Ranking - Trailing

Period VGHCX Return Category Return Low Category Return High Rank in Category (%)
YTD 7.4% -81.1% 25.3% 44.39%
1 Yr 14.0% -30.4% 77.3% 71.62%
3 Yr 10.3%* -15.9% 33.4% 68.72%
5 Yr 11.4%* -7.4% 32.2% 69.54%
10 Yr 15.5%* 9.8% 21.9% 67.16%

* Annualized

Total Return Ranking - Calendar

Period VGHCX Return Category Return Low Category Return High Rank in Category (%)
2020 3.6% -13.6% 178.2% 88.44%
2019 9.3% 3.8% 63.8% 97.24%
2018 -7.3% -25.3% 22.2% 57.66%
2017 11.2% -10.8% 54.4% 85.93%
2016 -16.2% -36.6% 11.6% 67.19%

NAV & Total Return History


VGHCX - Holdings

Concentration Analysis

VGHCX Category Low Category High VGHCX % Rank
Net Assets 50.5 B 238 K 50.5 B 0.56%
Number of Holdings 119 11 477 20.25%
Net Assets in Top 10 21.1 B 2.18 K 21.1 B 0.42%
Weighting of Top 10 40.83% 8.6% 94.7% 48.95%

Top 10 Holdings

  1. UnitedHealth Group Inc 5.57%
  2. AstraZeneca PLC 5.45%
  3. AstraZeneca PLC 5.45%
  4. AstraZeneca PLC 5.45%
  5. AstraZeneca PLC 5.45%
  6. AstraZeneca PLC 5.45%
  7. AstraZeneca PLC 5.45%
  8. AstraZeneca PLC 5.45%
  9. AstraZeneca PLC 5.45%
  10. AstraZeneca PLC 5.45%

Asset Allocation

Weighting Return Low Return High VGHCX % Rank
Stocks
98.40% 83.68% 101.79% 67.93%
Cash
1.59% -0.82% 10.99% 23.21%
Preferred Stocks
0.00% 0.00% 6.25% 66.67%
Other
0.00% -24.25% 9.11% 69.62%
Convertible Bonds
0.00% 0.00% 0.10% 64.98%
Bonds
0.00% 0.00% 15.36% 66.67%

Stock Sector Breakdown

Weighting Return Low Return High VGHCX % Rank
Healthcare
100.00% 63.33% 100.00% 32.07%
Utilities
0.00% 0.00% 1.14% 64.98%
Technology
0.00% 0.00% 19.13% 69.62%
Real Estate
0.00% 0.00% 6.13% 66.24%
Industrials
0.00% 0.00% 7.02% 67.51%
Financial Services
0.00% 0.00% 1.92% 77.22%
Energy
0.00% 0.00% 0.80% 64.98%
Communication Services
0.00% 0.00% 7.81% 67.09%
Consumer Defense
0.00% 0.00% 28.21% 67.09%
Consumer Cyclical
0.00% 0.00% 16.95% 68.78%
Basic Materials
0.00% 0.00% 8.13% 76.37%

Stock Geographic Breakdown

Weighting Return Low Return High VGHCX % Rank
US
71.00% 57.23% 100.70% 89.87%
Non US
27.40% 0.00% 42.77% 10.13%

VGHCX - Expenses

Operational Fees

VGHCX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 0.32% 0.08% 2.91% 78.63%
Management Fee 0.30% 0.00% 1.25% 6.70%
12b-1 Fee N/A 0.00% 1.00% N/A
Administrative Fee N/A 0.03% 0.25% N/A

Sales Fees

VGHCX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 0.00% 5.75% N/A
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

VGHCX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 2.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

VGHCX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 18.00% 0.00% 256.00% 13.33%

VGHCX - Distributions

Dividend Yield Analysis

VGHCX Category Low Category High VGHCX % Rank
Dividend Yield 0.16% 0.00% 2.44% 67.23%

Dividend Distribution Analysis

VGHCX Category Low Category High Category Mod
Dividend Distribution Frequency None Annually Monthly Monthly

Net Income Ratio Analysis

VGHCX Category Low Category High VGHCX % Rank
Net Income Ratio 0.95% -2.54% 1.92% 10.34%

Capital Gain Distribution Analysis

VGHCX Category Low Category High Capital Mode
Capital Gain Distribution Frequency None Annually Annually Annually

Dividend Payout History

View More +

VGHCX - Fund Manager Analysis

Managers

Jean Hynes


Start Date

Tenure

Tenure Rank

May 29, 2008

13.35

13.4%

Jean M. Hynes, CFA Chief Executive Officer, Managing Partner, and Portfolio Manager As the chief executive officer of Wellington Management Company LLP, Jean leads the firm in our mission to drive excellence for clients to positively impact millions of beneficiaries’ lives. In pursuit of that mission, she spends significant time meeting with clients globally as well as working to strengthen and support the firm’s people and capabilities. She also serves on a variety of internal management committees, including the executive, operating, and compensation committees. In addition, she is one o

Tenure Analysis

Category Low Category High Category Average Category Mode
0.03 24.06 6.71 1.46